This drug has a boxed warning. This is the most serious warning from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients to drug effects that may be dangerous.
If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 ...
If approved, the new autoinjector formulation would allow patients to administer furosemide at home reducing administration time from 5 hours to under 10 seconds.
MannKind Corporation beats Q3 estimates and sees FDA progress on ReadyFlow Autoinjector, presenting strong revenue growth potential. Learn more about MNKD stock here.
JUPITER, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner SQ Innovation Inc. has received approval from the U.S. Food and ...
The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. The influence of furosemide on prognosis after cardiac surgery is not fully ...
Two research projects on Exercise Induced Pulmonary Hemorrhage solicited by The Grayson-Jockey Club Research Foundation and funded in cooperation with The Jockey Club, the AAEP Foundation, Keeneland ...
Subcutaneous (SC) furosemide, a novel way to deliver diuretic therapy, may improve symptoms and functional capacity in patients with heart failure (HF) and worsening congestion, according to results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results